Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.

Vaccination is the most effective course of action to prevent influenza. About 150 million doses of influenza vaccines were distributed for the 2015-2016 season in the USA alone according to the Centers for Disease Control and Prevention. Vaccine dosage is calculated based on the concentration of he...

Full description

Saved in:
Bibliographic Details
Main Authors: Aziza P Manceur, Wei Zou, Anne Marcil, Eric Paquet, Christine Gadoury, Bozena Jaentschke, Xuguang Li, Emma Petiot, Yves Durocher, Jason Baardsnes, Manuel Rosa-Calatrava, Sven Ansorge, Amine A Kamen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0180314&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850078945288912896
author Aziza P Manceur
Wei Zou
Anne Marcil
Eric Paquet
Christine Gadoury
Bozena Jaentschke
Xuguang Li
Emma Petiot
Yves Durocher
Jason Baardsnes
Manuel Rosa-Calatrava
Sven Ansorge
Amine A Kamen
author_facet Aziza P Manceur
Wei Zou
Anne Marcil
Eric Paquet
Christine Gadoury
Bozena Jaentschke
Xuguang Li
Emma Petiot
Yves Durocher
Jason Baardsnes
Manuel Rosa-Calatrava
Sven Ansorge
Amine A Kamen
author_sort Aziza P Manceur
collection DOAJ
description Vaccination is the most effective course of action to prevent influenza. About 150 million doses of influenza vaccines were distributed for the 2015-2016 season in the USA alone according to the Centers for Disease Control and Prevention. Vaccine dosage is calculated based on the concentration of hemagglutinin (HA), the main surface glycoprotein expressed by influenza which varies from strain to strain. Therefore yearly-updated strain-specific antibodies and calibrating antigens are required. Preparing these quantification reagents can take up to three months and significantly slows down the release of new vaccine lots. Therefore, to circumvent the need for strain-specific sera, two anti-HA monoclonal antibodies (mAbs) against a highly conserved sequence have been produced by immunizing mice with a novel peptide-conjugate. Immunoblots demonstrate that 40 strains of influenza encompassing HA subtypes H1 to H13, as well as B strains from the Yamagata and Victoria lineage were detected when the two mAbs are combined to from a pan-HA mAb cocktail. Quantification using this pan-HA mAbs cocktail was achieved in a dot blot assay and results correlated with concentrations measured in a hemagglutination assay with a coefficient of correlation of 0.80. A competitive ELISA was also optimised with purified viral-like particles. Regardless of the quantification method used, pan-HA antibodies can be employed to accelerate process development when strain-specific antibodies are not available, and represent a valuable tool in case of pandemics. These antibodies were also expressed in CHO cells to facilitate large-scale production using bioreactor technologies which might be required to meet industrial needs for quantification reagents. Finally, a simulation model was created to predict the binding affinity of the two anti-HA antibodies to the amino acids composing the highly conserved epitope; different probabilities of interaction between a given amino acid and the antibodies might explain the affinity of each antibody against different influenza strains.
format Article
id doaj-art-84d646f3a5fe4208a105f5bca7c272fb
institution DOAJ
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-84d646f3a5fe4208a105f5bca7c272fb2025-08-20T02:45:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e018031410.1371/journal.pone.0180314Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.Aziza P ManceurWei ZouAnne MarcilEric PaquetChristine GadouryBozena JaentschkeXuguang LiEmma PetiotYves DurocherJason BaardsnesManuel Rosa-CalatravaSven AnsorgeAmine A KamenVaccination is the most effective course of action to prevent influenza. About 150 million doses of influenza vaccines were distributed for the 2015-2016 season in the USA alone according to the Centers for Disease Control and Prevention. Vaccine dosage is calculated based on the concentration of hemagglutinin (HA), the main surface glycoprotein expressed by influenza which varies from strain to strain. Therefore yearly-updated strain-specific antibodies and calibrating antigens are required. Preparing these quantification reagents can take up to three months and significantly slows down the release of new vaccine lots. Therefore, to circumvent the need for strain-specific sera, two anti-HA monoclonal antibodies (mAbs) against a highly conserved sequence have been produced by immunizing mice with a novel peptide-conjugate. Immunoblots demonstrate that 40 strains of influenza encompassing HA subtypes H1 to H13, as well as B strains from the Yamagata and Victoria lineage were detected when the two mAbs are combined to from a pan-HA mAb cocktail. Quantification using this pan-HA mAbs cocktail was achieved in a dot blot assay and results correlated with concentrations measured in a hemagglutination assay with a coefficient of correlation of 0.80. A competitive ELISA was also optimised with purified viral-like particles. Regardless of the quantification method used, pan-HA antibodies can be employed to accelerate process development when strain-specific antibodies are not available, and represent a valuable tool in case of pandemics. These antibodies were also expressed in CHO cells to facilitate large-scale production using bioreactor technologies which might be required to meet industrial needs for quantification reagents. Finally, a simulation model was created to predict the binding affinity of the two anti-HA antibodies to the amino acids composing the highly conserved epitope; different probabilities of interaction between a given amino acid and the antibodies might explain the affinity of each antibody against different influenza strains.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0180314&type=printable
spellingShingle Aziza P Manceur
Wei Zou
Anne Marcil
Eric Paquet
Christine Gadoury
Bozena Jaentschke
Xuguang Li
Emma Petiot
Yves Durocher
Jason Baardsnes
Manuel Rosa-Calatrava
Sven Ansorge
Amine A Kamen
Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
PLoS ONE
title Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
title_full Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
title_fullStr Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
title_full_unstemmed Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
title_short Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
title_sort generation of monoclonal pan hemagglutinin antibodies for the quantification of multiple strains of influenza
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0180314&type=printable
work_keys_str_mv AT azizapmanceur generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT weizou generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT annemarcil generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT ericpaquet generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT christinegadoury generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT bozenajaentschke generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT xuguangli generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT emmapetiot generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT yvesdurocher generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT jasonbaardsnes generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT manuelrosacalatrava generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT svenansorge generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza
AT amineakamen generationofmonoclonalpanhemagglutininantibodiesforthequantificationofmultiplestrainsofinfluenza